Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Mazurier

Showing results (61-70 of 130) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|May 15, 2002
Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factorL Hilbert, E Fressinaud, A S Ribba, et al.
Vox Sanguinis|January 1, 1991
In vitro evaluation of a very-high-purity, solvent/detergent-treated, von Willebrand factor concentrateC Mazurier, S Jorieux, C de Romeuf, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 15, 1998
Circulating von Willebrand factor antigen II in atherosclerosis: a comparison with von Willebrand factor and soluble thrombomodulinA D Blann, C de Romeuf, C Mazurier, et al.
Chest|February 1, 1985
Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDSF Fourrier, C Chopin, B Wallaert, et al.
British Journal of Haematology|May 1, 1994
Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domainS Jorieux, C Gaucher, G Piétu, et al.
Blood|February 1, 1992
The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factorS Jorieux, E A Tuley, C Gaucher, et al.
Thrombosis and Haemostasis|August 1, 1996
Combined hereditary disorders of haemophilia B Leyden (-6 G-->A) and type 1 von Willebrand diseaseG Pernod, C Vinciguerra, C Gaucher, et al.
Thrombosis Research|January 1, 1982
Preliminary results on the carbohydrate moiety of factor VIII/von Willebrand factor (FVIII/vWf)B Samor, C Mazurier, M Goudemand, et al.
European Journal of Biochemistry|May 1, 1993
Lactotransferrin binding to its platelet receptor inhibits platelet aggregationB Leveugle, J Mazurier, D Legrand, et al.
Blood|May 16, 2000
Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairmentS Jorieux, E Fressinaud, J Goudemand, et al.
Pageof 13

Showing results (61-70 of 130) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|May 15, 2002
Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factorL Hilbert, E Fressinaud, A S Ribba, et al.
Vox Sanguinis|January 1, 1991
In vitro evaluation of a very-high-purity, solvent/detergent-treated, von Willebrand factor concentrateC Mazurier, S Jorieux, C de Romeuf, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 15, 1998
Circulating von Willebrand factor antigen II in atherosclerosis: a comparison with von Willebrand factor and soluble thrombomodulinA D Blann, C de Romeuf, C Mazurier, et al.
Chest|February 1, 1985
Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDSF Fourrier, C Chopin, B Wallaert, et al.
British Journal of Haematology|May 1, 1994
Fine epitope mapping of monoclonal antibodies to the NH2-terminal part of von Willebrand factor (vWF) by using recombinant and synthetic peptides: interest for the localization of the factor VIII binding domainS Jorieux, C Gaucher, G Piétu, et al.
Blood|February 1, 1992
The mutation Arg (53)----Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factorS Jorieux, E A Tuley, C Gaucher, et al.
Thrombosis and Haemostasis|August 1, 1996
Combined hereditary disorders of haemophilia B Leyden (-6 G-->A) and type 1 von Willebrand diseaseG Pernod, C Vinciguerra, C Gaucher, et al.
Thrombosis Research|January 1, 1982
Preliminary results on the carbohydrate moiety of factor VIII/von Willebrand factor (FVIII/vWf)B Samor, C Mazurier, M Goudemand, et al.
European Journal of Biochemistry|May 1, 1993
Lactotransferrin binding to its platelet receptor inhibits platelet aggregationB Leveugle, J Mazurier, D Legrand, et al.
Blood|May 16, 2000
Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairmentS Jorieux, E Fressinaud, J Goudemand, et al.
Pageof 13